Christian Pfrepper/ResearchGate
Oct 3, 2025, 12:40
Christian Pfrepper and Team’s Letter on Emicizumab Plasma Concentration Measurment in EDTA plasma
RPTH Journal shared on LinkedIn:
”It’s mail day here at RPTH Journal
Check out this Research Letter from Christian Pfrepper and team showing that Emicizumab plasma concentration can be measured in EDTA plasma without relevant influence of residual FVIII.”
Read the full article here.
Article: Assessment of emicizumab levels in EDTA plasma
Authors: Christian Pfrepper, Annelie Siegemund, Tristan Klöter, Hagen Bönigk, Sirak Petros, Thomas Siegemund
Stay updated on all scientific advances in the field of hemophilia with Hemostasis Today.
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026